
Peter Andersen
CEO
Grupo Centroflora
About me
CEO — Centroflora Group
Holds a degree in Chemical Engineering from Oswaldo Cruz Colleges (1987), completed advanced studies in Industrial Engineering Processes at the University of California, Berkeley (1989), and earned an MBA in Family Business Management from Fundação Dom Cabral (2004). Over the past 25 years, he has built a career as both an executive and entrepreneur, gaining extensive experience in international business across multiple countries, working with diverse people and cultures. He has substantial expertise in M&A environments and investor relations, as well as in strategic business planning (medium and long term) and navigating economic crises in developing markets. He serves on the boards of several institutions, including philanthropic organizations. He is currently the President and CEO of the Centroflora Group, a position he has held since 1985.
Exhibitor Access Type
Exhibitor - In person & Online
Country
Canada
Markets Active In
AfricaEast Asia (e.g., China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g., UK, Russia, ex-CIS countries)Middle East Region (e.g., UAE, e.t.c)North America (e.g., USA, Canada)South Asia (e.g. India, Pakistan, Sri Lanka, e.t.c)South East Asia (e.g., Tailand, Philippines, Singapore, e.t.c.)
Geographical areas your company plans to expand into
Central America (e.g., Mexico)South America (e.g., Brazil, Colombia, e.t.c)
About me (Individual)
Department
Clinical Development
Job Function
Global Head of Technical & Scientific AffairsVP/Director
Purchasing Responsibility
Influence purchase
Offering/Interested In
Interested in: Department
Clinical DevelopmentGeneral ManagementResearch & DevelopmentSales/ Business Development
Interested in: Company Type
ConsultancyContract ServiceManufacturer/Innovator
Interested In: Company Certification
GMP
Interested In: Product Certification
FDA
Interested In
Interested In: Products & Service Category
BiopharmaceuticalsContract Services - Analytical & Lab ServicesContract Services - Pre-Clinical Trials, Clinical Trials Stages 1-4, CRO, Clinical DaFinished Dosage FormsPharmaceutical Packaging
Interested In: Biopharmaceuticals
CHO and cell linesContinuous BioprocessingDownstreamMonoclonal AntibodiesProtein ChemistryUpstream
Interested In: Contract Services- Analytical & Lab Services
Method ValidationStability Testing
Interested In: Contract Services - Pre Clinical Trials, Clinical Trials Stages 1-4, CRO, Clinical Data
Contract ResearchPharmacokinetics
Interested In: Finished Dosage Formulations
CapsulesInjectablesPowdersSoft tabsSuspensionsTablets
Interested In: Pharmaceutical Packaging
Blister PackagingClosuresDrug Delivery SystemsFill finish and packagingMedical Devices and Medical PackagingPharmaceutical PouchesSyringes/ Prefilled Syringes
Social media
Is member of

Patheon/Thermo

Thermo Fisher Scientific
Exhibitors
Thermo Fisher Scientific
ExhibitorsIs speaking at
China: Opportunities & Growth Potential for Global and Domestic Pharma
Peter Andersen · Grupo Centroflora
Annie Siu · Informa Pharma Intelligence
CDMO 2.0: Uncovering the Missing Element in Next-Generation Pharma Partnerships
Tuesday, October 24, 2023 12:15 PM to 12:35 PM
CPHI Content Hub - CC4.3
Peter Andersen · Grupo Centroflora
Panel: The CDMO Outlook
Tuesday, October 24, 2023 1:55 PM to 2:45 PM
CPHI Content Hub - CC4.3
Gil Roth · Pharma & Biopharma Outsourcing Association
Raman Sehgal · Molecule to Market
Peter Andersen · Grupo Centroflora
CDMO Roundtable: Outsourcing Trends
Room 201A
Dave Powell · Grand River Aseptic Manufacturing
Jim Miller · Oregon Freeze Dry
Peter Andersen · Grupo Centroflora
Tim Quinn · Actylis
Panel Discussion: Global Manufacturing Trend Outlook
Wednesday, December 11, 2024 10:15 AM to 11:15 AM
Future Theatre
Peter Andersen · Grupo Centroflora